Methotrexate: A Potential Preventive Treatment for Rheumatoid Arthritis in ACPA-Negative Patients
Recent findings from a long-term study suggest that methotrexate (MTX), a common medication for rheumatoid arthritis (RA), may help prevent the development of the disease in certain patients who test negative for anti-citrullinated protein antibodies (ACPA). This discovery, emerging from the TREAT EARLIER study, offers hope for those at risk of RA but lacking the… Read More: Methotrexate: A Potential Preventive Treatment for Rheumatoid Arthritis in ACPA-Negative… »